Leukemia & Lymphoma, Volume 57, Issue 10 (2016)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 57, Issue 10 (2016)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Volume 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

HLA: revisiting an old suspect in the complex pathogenesis of posttransplant lymphoproliferative disorders
Daan Dierickx, Ben Sprangers & Koen Van Besien
Pages: 2241-2242
Published online: 05 Jul 2016
CitationforHLA: revisiting an old suspect in the complex pathogenesis of posttransplant lymphoproliferative disorders | Full Text | References | PDF (231.5 KB) | Supplemental
  • 137 Views
  • 0 CrossRef citations
  • 0Altmetric
Basophils go wild when mosquitoes bite CLL
Clemens-Martin Wendtner & Aaron Polliack
Pages: 2243-2244
Published online: 16 May 2016
CitationforBasophils go wild when mosquitoes bite CLL | Full Text | References | PDF (227.9 KB) | Supplemental
  • 149 Views
  • 1 CrossRef citations
  • 0Altmetric

Reviews

The growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies
Thomas M. Baker & Michael J. Satlin
Pages: 2245-2258
Published online: 24 Jun 2016
AbstractforThe growing threat of multidrug-resistant Gram-negative infections in patients with hematologic malignancies | Full Text | References | PDF (1.3 MB) | Supplemental
  • 810 Views
  • 40 CrossRef citations
  • 0Altmetric
Ruxolitinib is effective in patients with intermediate-1 risk myelofibrosis: a summary of recent evidence
Claire N. Harrison, Moshe Talpaz & Adam J. Mead
Pages: 2259-2267
Published online: 27 Jul 2016
AbstractforRuxolitinib is effective in patients with intermediate-1 risk myelofibrosis: a summary of recent evidence | Full Text | References | PDF (1 MB) | Supplemental
  • 3066 Views
  • 16 CrossRef citations
  • 0Altmetric
Open Access

Original Articles: Clinical

Phase I study of idarubicin dose escalation for remission induction therapy in acute myeloid leukemia
Mark Hong Lee & Sung-Yong Kim
Pages: 2268-2274
Published online: 15 Feb 2016
AbstractforPhase I study of idarubicin dose escalation for remission induction therapy in acute myeloid leukemia | Full Text | References | PDF (554.7 KB) | Supplemental
  • 246 Views
  • 1 CrossRef citations
  • 0Altmetric
Long-term outcomes for children with acute lymphoblastic leukemia (ALL) treated on The Cancer Institute of New Jersey ALL trial (CINJALL)
Richard A. Drachtman, Margaret Masterson, Angela Shenkerman, Veena Vijayanathan & Peter D. Cole
Pages: 2275-2280
Published online: 16 Feb 2016
AbstractforLong-term outcomes for children with acute lymphoblastic leukemia (ALL) treated on The Cancer Institute of New Jersey ALL trial (CINJALL) | Full Text | References | PDF (599.4 KB) | Supplemental
  • 299 Views
  • 3 CrossRef citations
  • 0Altmetric
Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia
Anne-Claire Mamez, Emmanuel Raffoux, Sylvie Chevret, Virginie Lemiale, Nicolas Boissel, Emmanuel Canet, Benoît Schlemmer, Hervé Dombret, Elie Azoulay & Etienne Lengliné
Pages: 2281-2288
Published online: 05 Feb 2016
AbstractforPre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia | Full Text | References | PDF (746.1 KB) | Supplemental
  • 1405 Views
  • 32 CrossRef citations
  • 0Altmetric
B-cell acute lymphoblastic leukemia with mature phenotype and MLL rearrangement: report of five new cases and review of the literature
Elisa Olga Sajaroff, Adrian Mansini, Patricia Rubio, Cristina Noemí Alonso, Marta S. Gallego, Mariela C. Coccé, Silvia Eandi-Eberle, Andrea Raquel Bernasconi, Maria Ampatzidou, George Paterakis, Stefanos I. Papadhimitriou, Loizos Petrikkos, Vassilios Papadakis, Sophia Polychronopoulou, Jorge G. Rossi & Maria Sara Felice
Pages: 2289-2297
Published online: 08 Feb 2016
AbstractforB-cell acute lymphoblastic leukemia with mature phenotype and MLL rearrangement: report of five new cases and review of the literature | Full Text | References | PDF (1.7 MB) | Supplemental
  • 681 Views
  • 10 CrossRef citations
  • 0Altmetric
Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665
Rebecca DeBoer, Gregory Koval, Flora Mulkey, Meir Wetzler, Steven Devine, Guido Marcucci, Richard M. Stone, Richard A. Larson, Clara D. Bloomfield, Susan Geyer, Charles G. Mullighan & Wendy Stock
Pages: 2298-2306
Published online: 18 Feb 2016
AbstractforClinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665 | Full Text | References | PDF (1.2 MB) | Supplemental
  • 724 Views
  • 34 CrossRef citations
  • 0Altmetric
A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study
Mark H. Kirschbaum, Paul Frankel, Timothy W. Synold, Zhiliang Xie, Yun Yen, Leslie Popplewell, Robert Chen, Omar Aljitawi, Joseph M. Tuscano, Kenneth K. Chan & Edward M. Newman
Pages: 2307-2314
Published online: 19 Feb 2016
AbstractforA phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study | Full Text | References | PDF (726.9 KB) | Supplemental
  • 198 Views
  • 5 CrossRef citations
  • 0Altmetric
The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100 mg/m2 intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk myelodysplastic syndrome or acute leukemia
Anne Wanquet, Roberto Crocchiolo, Sabine Furst, Angela Granata, Catherine Faucher, Raynier Devillier, Samia Harbi, Claude Lemarie, Boris Calmels, Norbert Vey, Pierre Jean Weiller, Christian Chabannon, Luca Castagna, Didier Blaise & Jean El-Cheikh
Pages: 2315-2320
Published online: 17 Feb 2016
AbstractforThe efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100 mg/m2 intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk myelodysplastic syndrome or acute leukemia | Full Text | References | PDF (574.3 KB) | Supplemental
  • 246 Views
  • 4 CrossRef citations
  • 0Altmetric
Sustaining integrating imatinib and interferon-α into maintenance therapy improves survival of patients with Philadelphia positive acute lymphoblastic leukemia ineligible for allogeneic stem cell transplantation
Pu Kuang, Ting Liu, Ling Pan, Huanling Zhu, Yu Wu, Yuanxin Ye, Bing Xiang, Hongbing Ma, Hong Chang, Ting Niu, Xu Cui, Chuan He, Jianjun Li, Jie Ji, Jie Huang, Tian Dong, Yang Dai, Xiaojun Lu, Shenglan Qing, Huaxin Wu, Xiaogong Liang, Xiaoyu Wang & Chunnong Wu
Pages: 2321-2329
Published online: 16 Feb 2016
AbstractforSustaining integrating imatinib and interferon-α into maintenance therapy improves survival of patients with Philadelphia positive acute lymphoblastic leukemia ineligible for allogeneic stem cell transplantation | Full Text | References | PDF (1 MB) | Supplemental
  • 341 Views
  • 6 CrossRef citations
  • 0Altmetric
Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR)
Wolfgang Willenbacher, Shanmugapriya Thangavadivel, Richard Greil, Ella Willenbacher, Roman Weger, Claudia Manzl, Karin Jöhrer & Andrea Brunner
Pages: 2330-2341
Published online: 16 Feb 2016
AbstractforLow Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR) | Full Text | References | PDF (2.6 MB) | Supplemental
  • 439 Views
  • 4 CrossRef citations
  • 0Altmetric
Evaluation of serum markers in the LRF CLL4 trial: β2-microglobulin but not serum free light chains, is an independent marker of overall survival
Guy Pratt, Peter Thomas, Nicola Marden, Denis Alexander, Zadie Davis, David Hussey, Helen Parry, Stephen Harding, Daniel Catovsky, Joe Begley & David Oscier
Pages: 2342-2350
Published online: 08 Feb 2016
AbstractforEvaluation of serum markers in the LRF CLL4 trial: β2-microglobulin but not serum free light chains, is an independent marker of overall survival | Full Text | References | PDF (669 KB) | Supplemental
  • 167 Views
  • 3 CrossRef citations
  • 0Altmetric
Association between HLA-A1 and -A2 types and Epstein–Barr virus status of post-transplant lymphoproliferative disorder
Amelie Kinch, Christer Sundström, Gunnar Tufveson & Ingrid Glimelius
Pages: 2351-2358
Published online: 22 Apr 2016
AbstractforAssociation between HLA-A1 and -A2 types and Epstein–Barr virus status of post-transplant lymphoproliferative disorder | Full Text | References | PDF (1 MB) | Supplemental
  • 248 Views
  • 14 CrossRef citations
  • 0Altmetric
A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520
Soham D. Puvvada, Hongli Li, Lisa M. Rimsza, Steven H. Bernstein, Richard I. Fisher, Michael LeBlanc, Monika Schmelz, Betty Glinsmann-Gibson, Thomas P. Miller, Anne-Marie Maddox, Jonathan W. Friedberg, Sonali M. Smith & Daniel O. Persky
Pages: 2359-2369
Published online: 12 Jan 2016
AbstractforA phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520 | Full Text | References | PDF (4.3 MB) | Supplemental
  • 422 Views
  • 26 CrossRef citations
  • 0Altmetric
Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program
Pier Luigi Zinzani, Cinzia Pellegrini, Giuseppe Cerciello, Federico Monaco, Stefano Volpetti, Annalisa Peli, Emanuele Angelucci, Paolo Corradini, Maria Christina Cox, Attilio Guarini, Maurizio Musso, Paola Bresciani, Gabriella Amato, Atto Billio, Giuseppe Caparrotti, Amalia Figuera, Luca Nassi, Francesco Gaudio, Alberto Grossi, Francesco Onida, Michele Merli, Luigi Rigacci & Lisa Argnani
Pages: 2370-2374
Published online: 17 Feb 2016
AbstractforRomidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program | Full Text | References | PDF (457.9 KB) | Supplemental
  • 394 Views
  • 5 CrossRef citations
  • 0Altmetric
B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL)
Monica Balzarotti, Ercole Brusamolino, Emanuele Angelucci, Angelo Michele Carella, Umberto Vitolo, Eleonora Russo, Angelagiovanna Congiu, Manuel Gotti, Stefania Massidda, Barbara Botto, Giorgia Annechini, Michele Spina, Alessandro Re, Vittorio Ruggero Zilioli, Francesco Merli, Flavia Salvi, Caterina Stelitano, Maurizio Bonfichi, Marcello Rodari, Roberta Murru, Massimo Magagnoli, Antonella Anastasia, Rita Mazza, Laura Giordano & Armando Santoro
Pages: 2375-2381
Published online: 15 Feb 2016
AbstractforB-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL) | Full Text | References | PDF (593.4 KB) | Supplemental
  • 597 Views
  • 5 CrossRef citations
  • 0Altmetric
Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: 18F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy
Olivier Gheysens, Sanne Thielemans, Julie Morscio, Nancy Boeckx, Karolien E. Goffin, Christophe M. Deroose, Xavier Sagaert, Iwona Wlodarska, Gregor Verhoef, Daan Dierickx & Thomas Tousseyn
Pages: 2382-2388
Published online: 08 Feb 2016
AbstractforDetection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: 18F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy | Full Text | References | PDF (1.4 MB) | Supplemental
  • 259 Views
  • 15 CrossRef citations
  • 0Altmetric
Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia
Lata Rani, Nitin Mathur, Ajay Gogia, Sreenivas Vishnubhatla, Lalit Kumar, Atul Sharma, Divya Dube, Punit Kaur & Ritu Gupta
Pages: 2389-2400
Published online: 04 Mar 2016
AbstractforImmunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia | Full Text | References | PDF (1.3 MB) | Supplemental
  • 328 Views
  • 5 CrossRef citations
  • 0Altmetric

Original Articles: Research

Butyrate production from high-fiber diet protects against lymphoma tumor
Wei Wei, Wei Sun, Shanshan Yu, Yu Yang & Limei Ai
Pages: 2401-2408
Published online: 17 Feb 2016
AbstractforButyrate production from high-fiber diet protects against lymphoma tumor | Full Text | References | PDF (1.8 MB) | Supplemental
  • 792 Views
  • 57 CrossRef citations
  • 0Altmetric
Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cells
Neil E. Kay, Traci Sassoon, Charla Secreto, Sutapa Sinha, Tait D. Shanafelt, Asish K. Ghosh & Jack L. Arbiser
Pages: 2409-2416
Published online: 17 May 2016
AbstractforTris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cells | Full Text | References | PDF (1.5 MB) | Supplemental
  • 257 Views
  • 12 CrossRef citations
  • 0Altmetric

Letters to the Editor

Serum from a subset of patients with chronic lymphocytic leukemia and large local reactions to mosquito bites induces upregulation of CD63 surface expression on basophils in atopic donors
Jamma Li, Oliver Giles Best, Stephen P. Mulligan & Suran Loshana Fernando
Pages: 2417-2420
Published online: 22 Apr 2016
First Page PreviewforSerum from a subset of patients with chronic lymphocytic leukemia and large local reactions to mosquito bites induces upregulation of CD63 surface expression on basophils in atopic donors | Full Text | References | PDF (568.9 KB) | Supplemental
  • 233 Views
  • 3 CrossRef citations
  • 0Altmetric
Prediction of early death in adults with relapsed or refractory acute myeloid leukemia
Colin D. Godwin, Megan Othus, Morgan A. Powell, Sarah A. Buckley, Elihu H. Estey & Roland B. Walter
Pages: 2421-2424
Published online: 11 Jan 2016
First Page PreviewforPrediction of early death in adults with relapsed or refractory acute myeloid leukemia | Full Text | References | PDF (405.5 KB) | Supplemental
  • 278 Views
  • 6 CrossRef citations
  • 0Altmetric
Consolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment
Sandy Amorim, Isabelle Fleury, Nicolas Mounier, Stéphanie Harel, Pauline Brice & Catherine Thieblemont
Pages: 2425-2428
Published online: 11 Jan 2016
First Page PreviewforConsolidation therapy with mitoxantrone, ifosfamide and etoposide with or without rituximab before stem cell transplantation in relapsed diffuse large B-cell lymphoma patients failing second-line treatment | Full Text | References | PDF (417.6 KB) | Supplemental
  • 298 Views
  • 0 CrossRef citations
  • 0Altmetric
Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience
Luca Laurenti, Francesco Autore, Idanna Innocenti, Giovanni D’Arena, Marta Coscia, Patrizia Mondello, Patrizia Chiusolo, Silvia Bellesi, Dimitar G. Efremov, Simona Sica & Francesca Romana Mauro
Pages: 2429-2431
Published online: 27 Jan 2016
First Page PreviewforAutoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience | Full Text | References | PDF (292.1 KB) | Supplemental
  • 507 Views
  • 6 CrossRef citations
  • 0Altmetric
Investigating the synergistic mechanism between ibrutinib and daunorubicin in acute myeloid leukemia cells
Lianne E. Rotin, Marcela Gronda, Rose Hurren, XiaoMing Wang, Mark D. Minden, Malik Slassi & Aaron D. Schimmer
Pages: 2432-2436
Published online: 17 Feb 2016
First Page PreviewforInvestigating the synergistic mechanism between ibrutinib and daunorubicin in acute myeloid leukemia cells | Full Text | References | PDF (923.9 KB) | Supplemental
  • 371 Views
  • 2 CrossRef citations
  • 0Altmetric
A phase I study of elesclomol sodium in patients with acute myeloid leukemia
David Hedley, Aisha Shamas-Din, Sue Chow, Deborah Sanfelice, Andre C. Schuh, Joseph M. Brandwein, Matthew D. Seftel, Vikas Gupta, Karen W. L. Yee & Aaron D. Schimmer
Pages: 2437-2440
Published online: 05 Feb 2016
First Page PreviewforA phase I study of elesclomol sodium in patients with acute myeloid leukemia | Full Text | References | PDF (550.1 KB) | Supplemental
  • 493 Views
  • 31 CrossRef citations
  • 0Altmetric
A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia
Srinivas K. Tantravahi, Philippe Szankasi, Jamshid S. Khorashad, Kim-Hien Dao, Tibor Kovacsovics, Todd W. Kelley & Michael W. Deininger
Pages: 2441-2444
Published online: 08 Feb 2016
First Page PreviewforA phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia | Full Text | References | PDF (487.9 KB) | Supplemental
  • 395 Views
  • 18 CrossRef citations
  • 0Altmetric
Long-term molecular remission in Philadelphia-positive acute lymphoblastic leukemia elderly patient after dasatinib discontinuation
Ernesto Vigna, Massimo Gentile, Giovanna Giagnuolo, Anna Grazia Recchia, Sabrina Bossio, Laura De Stefano, Rosellina Morelli & Fortunato Morabito
Pages: 2445-2447
Published online: 15 Feb 2016
First Page PreviewforLong-term molecular remission in Philadelphia-positive acute lymphoblastic leukemia elderly patient after dasatinib discontinuation | Full Text | References | PDF (359.7 KB) | Supplemental
  • 261 Views
  • 2 CrossRef citations
  • 0Altmetric
Early relapse of severe chronic active Epstein-Barr virus infection with posterior reversible encephalopathy syndrome after reduced intensity stem cell transplantation with umbilical cord blood
Norimichi Hattori, Kohei Yamamoto, Yukiko Kawaguchi, Shun Fujiwara, Nana Arai, Nobuyuki Kabasawa, Hiroyuki Tsukamoto, Yui Uto, Kouji Yanagisawa, Bungo Saito & Tsuyoshi Nakamaki
Pages: 2448-2451
Published online: 15 Feb 2016
First Page PreviewforEarly relapse of severe chronic active Epstein-Barr virus infection with posterior reversible encephalopathy syndrome after reduced intensity stem cell transplantation with umbilical cord blood | Full Text | References | PDF (799.8 KB) | Supplemental
  • 136 Views
  • 2 CrossRef citations
  • 0Altmetric
Analysis of chronic myelogenous leukemia in an underserved, inner-city cohort shows a significant five year overall survival that is not affected by choice of tyrosine kinase inhibitor
Amer Assal, Baoxia Dong, Hina Khan, Ramadevi Medavarapu, Aditi Shastri, Kith Pradhan, Ellen Friedman, Ioannis Mantzaris, Murali Janakiram, Ramakrishna Battini, Noah Kornblum, Yiting Yu, Amit Verma, Ira Braunschweig & Olga Derman
Pages: 2452-2455
Published online: 17 Feb 2016
First Page PreviewforAnalysis of chronic myelogenous leukemia in an underserved, inner-city cohort shows a significant five year overall survival that is not affected by choice of tyrosine kinase inhibitor | Full Text | References | PDF (609.1 KB) | Supplemental
  • 118 Views
  • 1 CrossRef citations
  • 0Altmetric
Micafungin in invasive fungal infections in children with acute leukemia or undergoing stem cell transplantation
Jan Styczynski, Krzysztof Czyzewski, Mariusz Wysocki, Olga Zajac-Spychala, Jacek Wachowiak, Tomasz Ociepa, Tomasz Urasinski, Olga Gryniewicz-Kwiatkowska, Agnieszka Kolodziejczyk-Gietka, Bozenna Dembowska-Baginska, Danuta Perek, Malgorzata Salamonowicz, Lukasz Hutnik, Michal Matysiak, Karolina Siewiera, Jowita Frackiewicz, Krzysztof Kalwak, Wanda Badowska, Zofia Malas, Jolanta Gozdzik, Agnieszka Urbanek-Dadela, Grażyna Karolczyk, Weronika Stolpa, Grazyna Sobol, Zuzanna Gamrot, Mariola Woszczyk & Lidia Gil
Pages: 2456-2459
Published online: 16 Feb 2016
First Page PreviewforMicafungin in invasive fungal infections in children with acute leukemia or undergoing stem cell transplantation | Full Text | References | PDF (610.3 KB) | Supplemental
  • 420 Views
  • 1 CrossRef citations
  • 0Altmetric
A convenient prognostic score consisting of the Glasgow prognostic score and serum lactate dehydrogenase predicts clinical outcome in patients with diffuse large B-cell lymphoma
Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima & Yoshiharu Maeda
Pages: 2460-2463
Published online: 17 Feb 2016
First Page PreviewforA convenient prognostic score consisting of the Glasgow prognostic score and serum lactate dehydrogenase predicts clinical outcome in patients with diffuse large B-cell lymphoma | Full Text | References | PDF (528.9 KB) | Supplemental
  • 210 Views
  • 3 CrossRef citations
  • 0Altmetric
Impact of ruxolitinib treatment on the hemoglobin dynamics and the negative prognosis of anemia in patients with myelofibrosis
Haifa Kathrin Al-Ali, Viktoriya Stalbovskaya, Prashanth Gopalakrishna, Julian Perez-Ronco & Lynda Foltz
Pages: 2464-2467
Published online: 25 Feb 2016
First Page PreviewforImpact of ruxolitinib treatment on the hemoglobin dynamics and the negative prognosis of anemia in patients with myelofibrosis | Full Text | References | PDF (596.5 KB) | Supplemental
  • 1162 Views
  • 23 CrossRef citations
  • 0Altmetric
Soluble RANKL production by leukemic cells in a case of chronic lymphocytic leukemia with bone destruction
Mercedes Borge, María V Delpino, Enrique Podaza, Carmen Stanganelli, Virginia Palau-Nagore, Alejandro Roisman, Irma Slavutsky, María F. Palacios, Ignacio Ledesma, Antonio Arra, Alicia Díaz, Mirta Giordano, Romina Gamberale & Raimundo F. Bezares
Pages: 2468-2471
Published online: 25 Feb 2016
First Page PreviewforSoluble RANKL production by leukemic cells in a case of chronic lymphocytic leukemia with bone destruction | Full Text | References | PDF (1,003.2 KB) | Supplemental
  • 142 Views
  • 6 CrossRef citations
  • 0Altmetric
The contribution of multiple packed red blood cell transfusions toward cardiac and liver dysfunction in pediatric patients with acute myeloid leukemia*
Mohammed Al-Darwish, Neameh Farhan, Abdullah Al-Jebreen, Reem Allam, Ali Al-Ahmari, Amal Seraihy, Suleiman Al-Sweedan, Hassan El-Solh & Asim F. Belgaumi
Pages: 2472-2475
Published online: 25 Feb 2016
First Page PreviewforThe contribution of multiple packed red blood cell transfusions toward cardiac and liver dysfunction in pediatric patients with acute myeloid leukemia* | Full Text | References | PDF (395.3 KB) | Supplemental
  • 107 Views
  • 0 CrossRef citations
  • 0Altmetric
Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib
Evgenii Shumilov, Gerald Wulf, Philipp Ströbel, Justin Hasenkamp, Niels Hellige, Annalen Bleckmann, Detlef Haase, Friederike Braulke, Wolfram Jung, Julie Schanz, Mascha Binder, Lorenz Trümper & Ulrike Bacher
Pages: 2476-2480
Published online: 25 Feb 2016
First Page PreviewforOsteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib | Full Text | References | PDF (1.2 MB) | Supplemental
  • 222 Views
  • 4 CrossRef citations
  • 0Altmetric
Atypical BCR-ABL1 fusion transcripts in adult B-acute lymphoblastic leukemia, including a novel fusion transcript-e8a1
Prashant A. Deshpande, Vivi M. Srivastava, Sathya Mani, Senthamizhselvi Anandhan, J. Meena, Aby Abraham, Auro Viswabandya, Biju George, Alok Srivastava, Vikram Mathews & Poonkuzhali Balasubramanian
Pages: 2481-2484
Published online: 04 Mar 2016
First Page PreviewforAtypical BCR-ABL1 fusion transcripts in adult B-acute lymphoblastic leukemia, including a novel fusion transcript-e8a1 | Full Text | References | PDF (630.6 KB) | Supplemental
  • 138 Views
  • 3 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles